Back
Rocket Pharmaceuticals Stock Price Chart
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.
Sell
33
RCKT
Rocket Pharmaceuticals
Last Price:
15.68
Seasonality Move:
12.47%
7 Day Trial
ALL ACCESS PASS
$
7
Trump wins! Dow to 75,000? Details here
See the explosive "Document 20" details here.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RCKT is experiencing selling pressure, which indicates risk of future bearish movement.
Rocket Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.02 | Sell |
| 20-day SMA: | 17.27 | Sell |
| 50-day SMA: | 17.95 | Sell |
| 200-day SMA: | 22.47 | Sell |
| 8-day EMA: | 16.92 | Sell |
| 20-day EMA: | 17.18 | Sell |
| 50-day EMA: | 17.96 | Sell |
| 200-day EMA: | 20.73 | Sell |
Rocket Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.3 | Sell |
| Relative Strength Index (14 RSI): | 38.55 | Sell |
| Chaikin Money Flow: | -799252 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (16.64 - 17.74) | Sell |
| Bollinger Bands (100): | (17.13 - 22.05) | Sell |
Rocket Pharmaceuticals Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Rocket Pharmaceuticals Stock
Is Rocket Pharmaceuticals Stock a Buy?
- Rocket Pharmaceuticals share price is 16.03 while RCKT 8-day simple moving average is 17.02, which is a Sell signal.
- The stock price of RCKT is 16.03 while Rocket Pharmaceuticals 20-day SMA is 17.27, which makes it a Sell.
- Rocket Pharmaceuticals 50-day simple moving average is 17.95 while RCKT share price is 16.03, making it a Sell technically.
- RCKT stock price is 16.03 and Rocket Pharmaceuticals 200-day simple moving average is 22.47, creating a Sell signal.
RCKT Technical Analysis vs Fundamental Analysis
Sell
33
Rocket Pharmaceuticals (RCKT)
is a Sell
Is Rocket Pharmaceuticals a Buy or a Sell?
-
Rocket Pharmaceuticals stock is rated a Sell
The current Rocket Pharmaceuticals [RCKT] share price is $16.03. The Score for RCKT is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
Rocket Pharmaceuticals Stock Info
Market Cap:
1.46B
Price in USD:
16.03
Share Volume:
965.13K
Rocket Pharmaceuticals 52-Week Range
52-Week High:
32.53
52-Week Low:
15.92
Sell
33
Rocket Pharmaceuticals (RCKT)
is a Sell
Rocket Pharmaceuticals Share Price Forecast
-
What is the Rocket Pharmaceuticals stock price today?
The Rocket Pharmaceuticals stock price is 16.03 USD today. -
Will RCKT stock go up or go down?
Rocket Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Rocket Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Rocket Pharmaceuticals is overvalued.
Is Rocket Pharmaceuticals Stock a Buy?
- Rocket Pharmaceuticals share price is 16.03 while RCKT 8-day exponential moving average is 16.92, which is a Sell signal.
- The stock price of RCKT is 16.03 while Rocket Pharmaceuticals 20-day EMA is 17.18, which makes it a Sell.
- Rocket Pharmaceuticals 50-day exponential moving average is 17.96 while RCKT share price is 16.03, making it a Sell technically.
- RCKT stock price is 16.03 and Rocket Pharmaceuticals 200-day simple moving average is 20.73, creating a Sell signal.
Fundamental Analysis of Rocket Pharmaceuticals
Is Rocket Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.12 per share, and an increase next year of $0.27 per share.
Technical Analysis of Rocket Pharmaceuticals
Should I short Rocket Pharmaceuticals stock?
- RCKT Moving Average Covergence Divergence (MACD) indicator is -0.3, suggesting Rocket Pharmaceuticals is a Sell
- Rocket Pharmaceuticals Relative Strength Index (RSI) is 38.55, which suggest Rocket Pharmaceuticals is oversold
- The Bollinger Bands (25) for Rocket Pharmaceuticals is (16.64 - 17.74), which suggest Rocket Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Rocket Pharmaceuticals is (17.13 - 22.05), which suggest Rocket Pharmaceuticals is a Sell
* Rocket Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.